Cargando…
Targeted Therapy Against the Cell of Origin in Cutaneous Squamous Cell Carcinoma
Squamous cell carcinomas (SCC), including cutaneous SCCs, are by far the most frequent cancers in humans, accounting for 80% of all newly diagnosed malignancies worldwide. The old dogma that SCC develops exclusively from stem cells (SC) has now changed to include progenitors, transit-amplifying and...
Autores principales: | Goldie, Stephen J., Chincarini, Ginevra, Darido, Charbel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539622/ https://www.ncbi.nlm.nih.gov/pubmed/31060263 http://dx.doi.org/10.3390/ijms20092201 |
Ejemplares similares
-
Squamous Cell Carcinoma—A Summary of Novel Advances in Pathogenesis and Therapies
por: Khan, Imran, et al.
Publicado: (2022) -
Treatments of Squamous Cell Cancer
por: Charbel, Darido
Publicado: (2020) -
Loss of Grainy Head-Like 1 Is Associated with Disruption of the Epidermal Barrier and Squamous Cell Carcinoma of the Skin
por: Mlacki, Michal, et al.
Publicado: (2014) -
Stem Cells behind the Barrier
por: Cangkrama, Michael, et al.
Publicado: (2013) -
Long-Lived Epidermal Cancer-Initiating Cells
por: Youssef, Marina, et al.
Publicado: (2017)